Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone vs morphine for perioperative analgesia in thyroid ablation surgery
ChiCTR2600123619Phase 4Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Apr 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in thyroid nodule and thyroid cancer comparing Hydromorphone arm with Morphine arm (2 arms). Primary endpoints: Maximum intraoperative pain score and Incidence of adverse reactions. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
hydromorphonemorphine
03
Conditions
thyroid nodulethyroid cancer
Beyond the preview
Go deeper on ChiCTR2600123619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123619.